325 related articles for article (PubMed ID: 7810037)
1. [Clinical-immunological disorders in uveitis in patients with Behçet's syndrome].
Teplinskaia LE; Kaliberdina AF; Zaĭtseva NS; Bulanova TD; Katsnel'son LA
Vestn Oftalmol; 1994; 110(3):23-5. PubMed ID: 7810037
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-immunological study of 6 cases of Behçet's disease].
Silingardi V; Montemurno C; Venezia L; Franceschi C; Riva PC; Emilia G; Masi M; Merelli E; Torelli G; Licastro F; Fantini MP; Federico M
Minerva Med; 1979 Nov; 70(48):3269-84. PubMed ID: 390423
[TBL] [Abstract][Full Text] [Related]
3. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
Sugiura S; Sanefuji M; Ohno S
Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
[TBL] [Abstract][Full Text] [Related]
4. Behçet's disease. Clinical, endocrinological, and immunological aspects.
Ramalho PS; D'Almeida F; Magalhães A
Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):614-22. PubMed ID: 4534198
[No Abstract] [Full Text] [Related]
5. Uveitis in Behçet's disease.
Nussenblatt RB
Int Rev Immunol; 1997; 14(1):67-79. PubMed ID: 9203027
[TBL] [Abstract][Full Text] [Related]
6. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival ulcers in Behçet's disease.
Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis, immunopathogenesis, clinical picture and treatment of uveitis in nephropathies].
Teplinskaia LE; Kaliberdina AF
Vestn Oftalmol; 2000; 116(5):39-42. PubMed ID: 11221380
[TBL] [Abstract][Full Text] [Related]
9. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R
Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
12. Behçet's disease and streptococcal infection.
Namba K; Ueno T; Okita M
Jpn J Ophthalmol; 1986; 30(4):385-401. PubMed ID: 3586405
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance of the encephalon in 17 patients with ocular Behçet's disease].
Di Biasi C; Accorinti M; Trasimeni G; Pivetti Pezzi P; Melone A; Gualdi G
Radiol Med; 1997 Apr; 93(4):348-51. PubMed ID: 9244909
[TBL] [Abstract][Full Text] [Related]
14. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
Sakane T; Mochizuki M; Inaba G; Masuda K
Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
[TBL] [Abstract][Full Text] [Related]
15. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
[TBL] [Abstract][Full Text] [Related]
16. A case of Behçet's disease associated with membranous nephropathy.
Miura M; Tomino Y; Suga T; Endoh M; Nomoto Y; Sakai H; Furuya K; Kobayashi Y
Tokai J Exp Clin Med; 1984 Aug; 9(3):231-5. PubMed ID: 6537671
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in active Behçet's disease.
Gupta RC; O'Duffy JD; McDuffie FC; Meurer M; Jordon RE
Clin Exp Immunol; 1978 Nov; 34(2):213-8. PubMed ID: 737905
[TBL] [Abstract][Full Text] [Related]
18. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
Levinsky RJ; Lehner T
Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein iris angiography and anterior segment fluorophotometry in patients with Behçet's disease.
Yoshikawa K; Takahashi Y; Ohsone T; Wakatsuki Y; Kogure M
Jpn J Ophthalmol; 1987; 31(3):425-32. PubMed ID: 3430858
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with thymostimulin (TP-1) therapy. Preliminary findings].
Altomonte L; Zoli A; Siena D; Alessi F; Pestillo L; Mirone L
Minerva Med; 1986 Jun; 77(26):1243-7. PubMed ID: 3725151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
